166
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prognostic Value of Pace Variability, a Novel 6MWT-Derived Feature, in Patients with Chronic Obstructive Pulmonary Disease

, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 1555-1564 | Received 28 Mar 2023, Accepted 03 Jul 2023, Published online: 21 Jul 2023

References

  • Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
  • Kohli P, Pinto-Plata V, Divo M, et al. Functional capacity, health status, and inflammatory biomarker profile in a cohort of patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2015;35(5):348–355.
  • Smith LE, Moore E, Ali I, Smeeth L, Stone P, Quint JK. Prognostic variables and scores identifying the end of life in COPD: a systematic review. Int J Chron Obstruct Pulmon Dis. 2017;12:2239–2256.
  • Kakavas S, Kotsiou OS, Perlikos F, et al. Pulmonary function testing in COPD: looking beyond the curtain of FEV1. NPJ Prim Care Respir Med. 2021;31(1):23.
  • Laveneziana P, Di Paolo M, Palange P. The clinical value of cardiopulmonary exercise testing in the modern era. Eur Respir Rev. 2021;30(159):955.
  • Enright PL. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
  • Singh SJ, Puhan MA, Andrianopoulos V, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1447–1478.
  • Celli B, Tetzlaff K, Criner G, et al. The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool. Insights from the COPD Biomarker Qualification Consortium. Am J Respir Crit Care Med. 2016;194(12):1483–1493.
  • Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11(1):122.
  • Rebelo P, Brooks D, Marques A. Measuring intensity during free-living physical activities in people with chronic obstructive pulmonary disease: a systematic literature review. Ann Phys Rehabil Med. 2022;65(2):101607.
  • Puente-Maestu L, Palange P, Casaburi R, et al. Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J. 2016;47(2):429–460.
  • Andrianopoulos V, Wouters EF, Pinto-Plata VM, et al. Prognostic value of variables derived from the six-minute walk test in patients with COPD: results from the ECLIPSE study. Respir Med. 2015;109(9):1138–1146.
  • Haney TA Jr, Mercer JA. A description of variability of pacing in marathon distance running. Int J Exerc Sci. 2011;4(2):133–140.
  • St Clair Gibson A, Noakes TD. Evidence for complex system integration and dynamic neural regulation of skeletal muscle recruitment during exercise in humans. Br J Sports Med. 2004;38(6):797–806.
  • Palmer GS, Noakes TD, Hawley JA. Effects of steady-state versus stochastic exercise on subsequent cycling performance. Med Sci Sports Exerc. 1997;29(5):684–687.
  • Ely MR, Martin DE, Cheuvront SN, Montain SJ. Effect of ambient temperature on marathon pacing is dependent on runner ability. Med Sci Sports Exerc. 2008;40(9):1675–1680.
  • Cheng SL, Li YR, Huang N, et al. Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan. Int J Chron Obstruct Pulmon Dis. 2021;16:2869–2881.
  • Cheng SL, Lin CH, Chu KA, et al. Update on guidelines for the treatment of COPD in Taiwan using evidence and GRADE system-based recommendations. J Formos Med Assoc. 2021;120(10):1821–1844.
  • Golpe R, Pérez-de-Llano LA, Méndez-Marote L, Veres-Racamonde A. Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients. Respir Care. 2013;58(8):1329–1334.
  • Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1384–1387.
  • Johnson MJ, Close L, Gillon SC, Molassiotis A, Lee PH, Farquhar MC. Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis. Eur Respir J. 2016;47(6):1861–1864.
  • Billat VL, Slawinski J, Danel M, Koralsztein JP. Effect of free versus constant pace on performance and oxygen kinetics in running. Med Sci Sports Exerc. 2001;33(12):2082–2088.
  • Johnston KN, Potter AJ, Phillips AC. Minimal important difference and responsiveness of 2-minute walk test performance in people with COPD undergoing pulmonary rehabilitation. Int J Chron Obstruct Pulmon Dis. 2017;12:2849–2857.
  • Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007;96(5):644–647.
  • Lukacsovits J, Szollosi G, Varga JT. Cardiovascular effects of exercise induced dynamic hyperinflation in COPD patients-Dynamically hyperinflated and non-hyperinflated subgroups. PLoS One. 2023;18(1):e0274585.
  • Deaner RO, Carter RE, Joyner MJ, Hunter SK. Men are more likely than women to slow in the marathon. Med Sci Sports Exerc. 2015;47(3):607–616.
  • Trubee NW, Vanderburgh PM, Diestelkamp WS, Jackson KJ. Effects of heat stress and sex on pacing in marathon runners. J Strength Cond Res. 2014;28(6):1673–1678.
  • March DS, Vanderburgh PM, Titlebaum PJ, Hoops ML. Age, sex, and finish time as determinants of pacing in the marathon. J Strength Cond Res. 2011;25(2):386–391.
  • de Koning JJ, Foster C, Bakkum A, et al. Regulation of pacing strategy during athletic competition. PLoS One. 2011;6(1):e15863.
  • Roelands B, de Koning J, Foster C, Hettinga F, Meeusen R. Neurophysiological determinants of theoretical concepts and mechanisms involved in pacing. Sports Med. 2013;43(5):301–311.
  • Noakes TD, Peltonen JE, Rusko HK. Evidence that a central governor regulates exercise performance during acute hypoxia and hyperoxia. J Exp Biol. 2001;204(Pt 18):3225–3234.
  • Dajczman E, Wardini R, Kasymjanova G, Préfontaine D, Baltzan MA, Wolkove N. Six minute walk distance is a predictor of survival in patients with chronic obstructive pulmonary disease undergoing pulmonary rehabilitation. Can Respir J. 2015;22(4):225–229.
  • Mura M, Porretta MA, Bargagli E, et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study. Eur Respir J. 2012;40(1):101–109.
  • Mancuzo EV, Soares MR, Pereira CAC. Six-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil. J Bras Pneumol. 2018;44(4):267–272.
  • Casanova C, Celli BR, Barria P, et al. The 6-min walk distance in healthy subjects: reference standards from seven countries. Eur Respir J. 2011;37(1):150–156.
  • Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–1446.
  • Hernandes NA, Wouters EF, Meijer K, Annegarn J, Pitta F, Spruit MA. Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J. 2011;38(2):261–267.